Four transcription factors (Bcl11a, Grhl3, Prox1, Sox11) activated in Brca1-/- mouse tumors and basal-like human breast cancers across multiple datasets were chosen for validation studies, and all were confirmed to be embryonic-enriched and highly expressed by some tumors. This evidence concerns the gene PROX1 and breast cancer.